Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides comprehensive analytical and IND enabling services, as well as drug substance development and manufacturing across the entire drug lifecycle.

With over 40 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs.

Services & Capabilities

Drug substance:

• Custom development
• Custom manufacturing
• Generic APIs
• Specialized technologies including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs.

Drug product:

• Custom development
• Custom manufacturing
• Solid state science & pre-formulation development
• Conventional dosage forms including oral solids, semi-solids and liquids
• Specialized dosage forms including fixed dose combination and pediatric

Analytical services:

• Method development & validation
• Material characterization
• Compendial & release testing
• Stability storage & testing
• Bioanalytical testing
• Microbiology & cleanroom services
• Impurity isolation, identification & characterization
• Reference standard qualification

Facilities

Cambrex has a presence in thirteen locations globally including headquarters in East Rutherford, NJ, USA.

North American development and manufacturing facilities:

• Agawam, MA, USA
• Charles City, IA, USA
• Durham, NC, USA
• High Point, NC, USA
• Longmont, CO, USA
• Waltham, MA, USA

European development and manufacturing facilities:

• Edinburgh, UK
• Karlskoga, Sweden
• Liège, Belgium
• Paullo (Milan), Italy
• Tallinn, Estonia
• Waterford, Ireland
• Wiesbaden, Germany